Related references
Note: Only part of the references are listed.Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Roberto Alva-Ruiz et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers
Sun Kyung Jeon et al.
EUROPEAN RADIOLOGY (2022)
Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review
T. H. Perik et al.
ABDOMINAL RADIOLOGY (2022)
Distal Pancreatectomy with Celiac Axis Resection (Modified Appleby Procedure) and Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma After FOLFIRINOX Chemotherapy and Chemoradiation Therapy
Pierre-Emmanuel Colombo et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11)
Carolin Zimmermann et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2021)
Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.
Salah-Eddin Al-Batran et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.
Matthew H. G. Katz et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma
Yoshifumi Noda et al.
ABDOMINAL RADIOLOGY (2021)
European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
G. Carioli et al.
ANNALS OF ONCOLOGY (2021)
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
R. Casolino et al.
ANNALS OF ONCOLOGY (2021)
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Valeria Merz et al.
FRONTIERS IN ONCOLOGY (2021)
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Volker Kunzmann et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
Q. P. Janssen et al.
BMC CANCER (2021)
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2
Kim A. Reiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Effect of deep learning image reconstruction in the prediction of resectability of pancreatic cancer: Diagnostic performance and reader confidence
Peijie Lyu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2021)
Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery?
Kartik S. Jhaveri et al.
CANCER IMAGING (2021)
Pancreatic Adenocarcinoma, Version 2.2021
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Abdominal splenosis and its differential diagnoses: What the radiologist needs to know
Federica Vernuccio et al.
CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY (2021)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals
Naveen M. Kulkarni et al.
ABDOMINAL RADIOLOGY (2020)
Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability
Mariangela Dimarco et al.
ABDOMINAL RADIOLOGY (2020)
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease
Naveen M. Kulkarni et al.
ABDOMINAL RADIOLOGY (2020)
Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Amir A. Borhani et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
Eileen M. O'Reilly et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Michael J. Pishvaian et al.
LANCET ONCOLOGY (2020)
Patient outcome according to the 2017 international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma
J. Medrano et al.
PANCREATOLOGY (2020)
Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis
Mao Ye et al.
HPB (2020)
Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9
Haidy Nasief et al.
FRONTIERS IN ONCOLOGY (2020)
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Philip A. Philip et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer
Talia Golan et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.
Paula Ghaneh et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA).
Davendra Sohal et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
Takahiro Yokose et al.
CANCER MEDICINE (2020)
A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score
Charlotte Maulat et al.
CANCERS (2020)
Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
Khaled Y. Elbanna et al.
INSIGHTS INTO IMAGING (2020)
Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score
Dong Wook Kim et al.
RADIOLOGY (2020)
Solid pseudopapillary Tumor of the Pancreas: Radiological and surgical review
Darshan Gandhi et al.
CLINICAL IMAGING (2020)
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial
Francesca Simionato et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis
Bo Ram Kim et al.
EUROPEAN RADIOLOGY (2019)
Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study
Alessandro Beleu et al.
CANCERS (2019)
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2019)
Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience
Ahmed Hamdy et al.
RADIOLOGY (2019)
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
Laura Maggino et al.
JAMA SURGERY (2019)
Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement
Ijin Joo et al.
RADIOLOGY (2019)
Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
Manisha Palta et al.
PRACTICAL RADIATION ONCOLOGY (2019)
CT perfusion and diffusion-weighted MR imaging of pancreatic adenocarcinoma: can we predict tumor grade using functional parameters?
Jelena Djokic Kovac et al.
ACTA RADIOLOGICA (2019)
Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis
Yoon Suk Lee et al.
SCIENTIFIC REPORTS (2019)
Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI
D. M. Riviere et al.
ABDOMINAL RADIOLOGY (2019)
A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
R. Tuli et al.
EBIOMEDICINE (2019)
Appleby Procedure (Distal Pancreatectomy With Celiac Artery Resection) for Locally Advanced Pancreatic Carcinoma: Indications, Outcomes, and Imaging
Roberto Cannella et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 Mutation
Shun Yu et al.
JCO PRECISION ONCOLOGY (2019)
Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis
Manav Bhalla et al.
ABDOMINAL RADIOLOGY (2018)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Shuji Isaji et al.
PANCREATOLOGY (2018)
PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study
Entesar Dalah et al.
TRANSLATIONAL ONCOLOGY (2018)
Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT
Satomi Kawamoto et al.
ABDOMINAL RADIOLOGY (2018)
Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis
Bhavik N. Patel et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study
Anne-Marie Marion-Audibert et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy
Valentina Ciaravino et al.
ANTICANCER RESEARCH (2018)
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)
Lilian Schwarz et al.
BMC CANCER (2018)
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria
Seung Baek Hong et al.
RADIOLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy
Eric A. Mellon et al.
ACTA ONCOLOGICA (2017)
CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma
Mathilde Wagner et al.
EUROPEAN RADIOLOGY (2017)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Interim analysis of perioperative modified FOLFIRINOX (mFOLFIRINOX) in resectable pancreatic cancer (PC).
Michael Cecchini et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial-1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial
Knut Jorgen Labori et al.
BMC SURGERY (2017)
Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study
Xiaojian Chen et al.
PLOS ONE (2017)
Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification
J. W. Gilbert et al.
ANNALS OF ONCOLOGY (2017)
Common and uncommon pitfalls in pancreatic imaging: it is not always cancer
F. Vernuccio et al.
ABDOMINAL RADIOLOGY (2016)
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial
Pascal Hammel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker et al.
LANCET ONCOLOGY (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages
Kezhong Tang et al.
PANCREATOLOGY (2016)
Dual-Energy Perfusion-CT in Recurrent Pancreatic Cancer - Preliminary Results
F. Fritz et al.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2016)
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer Alliance for Clinical Trials in Oncology Trial A021101
Matthew H. G. Katz et al.
JAMA SURGERY (2016)
Radiological evaluation of response to neoadjuvant treatment in pancreatic cancer
C. Cassinotto et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2016)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
Multireader evaluation of lesion conspicuity in small pancreatic adenocarcinomas: complimentary value of iodine material density and low keV simulated monoenergetic images using multiphasic rapid kVp-switching dual energy CT
Michelle M. McNamara et al.
ABDOMINAL IMAGING (2015)
Locally Advanced Pancreatic Adenocarcinoma: Reassessment of Response with CT after Neoadjuvant Chemotherapy and Radiation Therapy
Christophe Cassinotto et al.
RADIOLOGY (2014)
Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
Mahmoud M. Al-Hawary et al.
RADIOLOGY (2014)
Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
Maximilian Bockhorn et al.
SURGERY (2014)
Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
Matthew H. G. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: Optimization of energy level viewing significantly increases lesion contrast
B. N. Patel et al.
CLINICAL RADIOLOGY (2013)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Split-Bolus Spectral Multidetector CT of the Pancreas: Assessment of Radiation Dose and Tumor Conspicuity
Olga R. Brook et al.
RADIOLOGY (2013)
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Pathologic Response to Preoperative Chemoradiation Therapy in Patients With Resectable T3 Pancreatic Cancer
Hirotada Kittaka et al.
WORLD JOURNAL OF SURGERY (2013)
Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression
Vikas Dudeja et al.
HPB (2013)
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
Matthew H. G. Katz et al.
CANCER (2012)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno et al.
CELL (2012)
Small (≤20 mm) Pancreatic Adenocarcinomas: Analysis of Enhancement Patterns and Secondary Signs with Multiphasic Multidetector CT
Soon Ho Yoon et al.
RADIOLOGY (2011)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Visually Isoattenuating Pancreatic Adenocarcinoma at Dynamic-Enhanced CT: Frequency, Clinical and Pathologic Characteristics, and Diagnosis at Imaging Examinations
Jin Hee Kim et al.
RADIOLOGY (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and Overview of the Conference
Jean-Nicolas Vauthey et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Mark P. Callery et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Effects of Neoadjuvant Combined Chemotherapy and Radiation Therapy on the CT Evaluation of Resectability and Staging in Patients with Pancreatic Head Cancer
Yeo-Eun Kim et al.
RADIOLOGY (2009)
Perfusion CT: Noninvasive Surrogate Marker for Stratification of Pancreatic Cancer Response to Concurrent Chemo- and Radiation Therapy
Mi-Suk Park et al.
RADIOLOGY (2009)
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
Gauri R. Varadhachary et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Detection of small pancreatic tumors with multiphasic helical CT
YL Bronstein et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2004)
Share Paper
